Walgreens Boots Alliance, Inc. (WBA)
After hours:
Chart Events
Performance Outlook
| Previous Close | 37.71 |
| Open | 37.70 |
| Bid | 37.08 x 1800 |
| Ask | 37.12 x 800 |
| Day's Range | 36.92 - 37.75 |
| 52 Week Range | 30.39 - 50.19 |
| Volume | |
| Avg. Volume | 6,485,076 |
| Market Cap | 31.99B |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | 7.37 |
| EPS (TTM) | 5.03 |
| Earnings Date | Mar 29, 2023 - Apr 03, 2023 |
| Forward Dividend & Yield | 1.92 (5.16%) |
| Ex-Dividend Date | Feb 15, 2023 |
| 1y Target Est | 41.32 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for WBA
Related Research
- Walgreens Boots Alliance, Inc.Analyst Report: Walgreens Boots Alliance IncWalgreens Boots Alliance Inc. based in Deerfield, Illinois, is a holding company created in December 2014 when Walgreen completed its purchase of privately held Alliance Boots. The company generated $133 billion in FY22 sales from continuing operations. After divesting its healthcare distribution business WBA has presence in more than 9 countries. About 85% of revenue is from the United States. The company has over 14,000 stores under the Walgreen, Duane Reade and Boots names. WBA owns about 25% of AmerisourceBergen. WBA's fiscal year ends on August 31. The company has reclassified its operations again. The new organization has a United States Retail Pharmacy unit, an International unit, and a U.S. Healthcare segment which includes recent investments in VillageMD, CareCentrix and Shields Health Solutions.RatingFair ValueEconomic Moat23 days agoArgus Research
- Zacks
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $37.09, marking a -1.64% move from the previous day.
- Motley Fool
Where Will Walgreens Boots Alliance Be in 5 Years?
In early 2028, pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) will likely be a larger and more diversified business, assuming its foray into primary care goes according to plan. The pharmacy company finds itself in the midst of an attempt to diversify into providing healthcare services like primary care during a time when its top and bottom lines are looking somewhat weak. As you can see, both its quarterly revenue and net income haven't shown much sign of improvement over the last five years.
- Benzinga
Attorney Generals Of Several States Warn CVS, Walgreens Against Mailing Abortion Medication
Republican attorneys general in 20 states warned CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA) against mailing abortion pills in their jurisdictions. Also Read: Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow. “We emphasize that it is our responsibility as State Attorneys General to uphold the law and protect the health, safety, and well-being of women and unborn children in our states,” the attorney generals said in lett
